Condition
Neurodevelopment Outcome clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Neurodevelopment Outcome clinical trials that are recruiting, at sites in 4 countries (most in Bangladesh (1), Pakistan (1), United States (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Neurodevelopment Outcome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Micronutrient Enhancement for Development and Health in Adolescent Girls | Phase 3 | Rangpur City | Recruiting | Jul 10, 2026 |
| Hospital-to-home support (H-HOPE) for infants with congenital defects after neonatal surgery and their parents | — | Chicago, Illinois | Recruiting | Jan 28, 2026 |
| Turkish BRIEF version of the Hammersmith Infant Neurological Examination (HINE) | — | Kahramanmaraş, Onikişubat | Recruiting | Sep 19, 2025 |
| MOM-CARE: enhanced micronutrient supplements during and after pregnancy to help babies be born healthier and grow better | Phase 3 | Karachi, Sindh | Recruiting | Jun 19, 2025 |
All recruiting trials (4)
-
Micronutrient Enhancement for Development and Health in Adolescent Girls
This study tests whether daily micronutrient supplements (MMS or MMS+), compared with weekly iron-folic acid, can improve school performance and growth in 10- to 18-year-old girls in rural Bangladesh.
-
Hospital-to-home support (H-HOPE) for infants with congenital defects after neonatal surgery and their parents
This program tests whether H-HOPE helps infants born with congenital defects who need neonatal surgery — and their parents — improve feeding, growth, early development, and parental mental health.
-
Turkish BRIEF version of the Hammersmith Infant Neurological Examination (HINE)
This project tests a short Turkish BRIEF-HINE neurological screening for infants who are at high risk of neurodevelopmental problems to see if it works well in routine clinics.
-
MOM-CARE: enhanced micronutrient supplements during and after pregnancy to help babies be born healthier and grow better
This will test whether an enhanced multivitamin supplement (MMS Plus) given during pregnancy and after birth helps babies born to women in peri-urban Karachi have better birth outcomes and faster early growth than standard MMS or iron/folic acid.
Related topics
Quick answers
How many Neurodevelopment Outcome clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Bangladesh (1 trial), Pakistan (1 trial), United States (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.